Rchr
J-GLOBAL ID：202001010284564822
Update date: May. 06, 2024
Okazaki Keito
オカザキ ケイト | Okazaki Keito
Affiliation and department：
Research theme for competitive and other funds (2)：
- 2022 - 2024 Regnase-1による転写後制御が創出するがん悪性化機構の解明
- 2020 - 2022 Research for unveiled molecular mechanism underlying cancer malignancy
Papers (11)：
-
Kazuki Hayasaka, Shinya Ohkouchi, Ryoko Saito-Koyama, Yamato Suzuki, Keito Okazaki, Hiroki Sekine, Tatsuaki Watanabe, Hozumi Motohashi, Yoshinori Okada. Aging Exacerbates Murine Lung Ischemia-Reperfusion Injury by Excessive Inflammation and Impaired Tissue Repair Response. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2023
-
Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi. NRF2 signalling in cytoprotection and metabolism. British journal of pharmacology. 2023
-
Keito Okazaki, Hayato Anzawa, Fumiki Katsuoka, Kengo Kinoshita, Hiroki Sekine, Hozumi Motohashi. CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells. The Journal of Biochemistry. 2022. 171. 5. 567-578
-
Keito Okazaki, Hayato Anzawa, Zun Liu, Nao Ota, Hiroshi Kitamura, Yoshiaki Onodera, Md Morshedul Alam, Daisuke Matsumaru, Takuma Suzuki, Fumiki Katsuoka, et al. Publisher Correction: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers. Nature communications. 2021. 12. 1. 506-506
-
Keito Okazaki, Hayato Anzawa, Zun Liu, Nao Ota, Hiroshi Kitamura, Yoshiaki Onodera, Md Morshedul Alam, Daisuke Matsumaru, Takuma Suzuki, Fumiki Katsuoka, et al. Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers. Nature communications. 2020. 11. 1. 5911-5911
ｍore...
Lectures and oral presentations (1)：
-
Enhancer Remodeling at the NOTCH3 Locus Licenses NRF2 for the Promotion of a Stem-like Phenotype in Lung Cancers.
(Environmental Response V/17th JBS Biofrontier Symposium 2019)
Professional career (1)：
Return to Previous Page
